Helmet Continuous Positive Airway Pressure (CPAP) Versus Oxygen Venturi in Severe Acute Respiratory Failure in Pneumonia

NCT ID: NCT01383213

Last Updated: 2014-02-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

81 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the efficacy of CPAP application by a helmet and O2 administration by a Venturi mask in terms of achievement of criteria for endotracheal intubation during severe acute respiratory failure caused by pneumonia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pneumonia is one of the commonest causes of hospitalised acute respiratory failure with a mortality rate up to 30%.

Continuous Positive Airway Pressure (CPAP) has ben recently proved to be effective. To date, however, no prospective randomised study has been published on the comparison between CPAP and O2 administration by Venturi mask for the treatment of severe acute respiratory failure in patients with pneumonia. .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia Respiratory Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CPAP (group A)

group A will be treated with CPAP using a helmet, initial PEEP of 10 cmH20 and an FiO2 set in order to maintain SpO2 ≥92%

Group Type EXPERIMENTAL

Helmet CPAP

Intervention Type OTHER

patient in group CPAP will be treated with CPAP until reaching clinical stability, or criteria of endotracheal intubation

oxygen therapy (group B)

group B (standard treatment) will be treated with oxygen therapy by Venturi mask with an FiO2 set in order to maintain SpO2 ≥92%.

Group Type ACTIVE_COMPARATOR

Oxygen therapy

Intervention Type OTHER

patient in group oxygen therapy by Venturi Mask will be treated with oxygen until reaching clinical stability, or criteria of endotracheal intubation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxygen therapy

patient in group oxygen therapy by Venturi Mask will be treated with oxygen until reaching clinical stability, or criteria of endotracheal intubation

Intervention Type OTHER

Helmet CPAP

patient in group CPAP will be treated with CPAP until reaching clinical stability, or criteria of endotracheal intubation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men and women of any ethnic group;
* age ≥18 years;
* dyspnoea at rest with respiratory rate (RR) ≥30 breath/min or sign of respiratory distress
* PaO2/FiO2 ratio≤250 evaluated during oxygen therapy supplied at least 1 hour through a Venturi mask with FiO2 ≥0,50
* diagnosis of pneumonia as unique cause of severe acute respiratory failure
* informed consent from each patient or from the closest relative in case of the patient's incapacity to give it

Exclusion Criteria

* diagnosis of other causes of severe acute respiratory failure
* unstable angina or acute myocardial infarction;
* acute respiratory acidosis with pH \<7,35 and PaCO2 \>45 mmHg;
* systolic BP \<90 mmHg despite fluid resuscitation or vasopressors;
* severe arrhythmias;
* convulsions;
* degree of consciousness, Kelly score\>3;
* swallowing disturbance with increasing risk of aspiration pneumonia;
* inability to protect the airway;
* recent facial trauma or burn;
* non-collaborative patient;
* presence of open wounds (head, thorax, abdomen);
* respiratory arrest or need of intubation;
* pregnancy or suspect of pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Milan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francesco Blasi

Professor of Respiratory Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roberto Cosentini, MD

Role: PRINCIPAL_INVESTIGATOR

Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico - Milano - Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico

Milan, Milan, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Cosentini R, Brambilla AM, Aliberti S, Bignamini A, Nava S, Maffei A, Martinotti R, Tarsia P, Monzani V, Pelosi P. Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial. Chest. 2010 Jul;138(1):114-20. doi: 10.1378/chest.09-2290. Epub 2010 Feb 12.

Reference Type BACKGROUND
PMID: 20154071 (View on PubMed)

Squadrone V, Massaia M, Bruno B, Marmont F, Falda M, Bagna C, Bertone S, Filippini C, Slutsky AS, Vitolo U, Boccadoro M, Ranieri VM. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med. 2010 Oct;36(10):1666-1674. doi: 10.1007/s00134-010-1934-1. Epub 2010 Jun 9.

Reference Type BACKGROUND
PMID: 20533022 (View on PubMed)

Confalonieri M, Potena A, Carbone G, Porta RD, Tolley EA, Umberto Meduri G. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1585-91. doi: 10.1164/ajrccm.160.5.9903015.

Reference Type BACKGROUND
PMID: 10556125 (View on PubMed)

Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1438-44. doi: 10.1164/rccm.200301-072OC. Epub 2003 Sep 18.

Reference Type BACKGROUND
PMID: 14500259 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SCAPOVERSO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Helmet NIV in Acute Respiratory Failure
NCT05022173 ACTIVE_NOT_RECRUITING NA